España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Global X Genomics & Biotechnology ETF
GNOM
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$9.89
0.19
1.96%
At close: -
$9.79
-0.10
-1.01%
After Hours: Dec 19, 9:29 AM EDT
Get Report
Comment
Overview
News
Holdings
Dividends
Short Interest
Latest news for Global X Genomics & Biotechnology ETF (NASDAQ:GNOM)
Global X Genomics & Biotechnology ETF (NASDAQ: GNOM)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, November 05, 2020
68 Stocks Trading Near 52-Week Highs Just Aft...
Benzinga Newsdesk
Tuesday, May 26, 2020
3 Genomics ETFs Worth Jumping For
ETF Professor
Thursday, October 10, 2019
This High Growth ETF May Not Be As Pricey As You Think
ETF Professor
Wednesday, April 10, 2019
Get In On Genomics With This New ETF
ETF Professor
Wednesday, March 13, 2013
Benzinga Market Primer: Wednesday, March 13
Benzinga
Tuesday, February 26, 2013
BGI-Shenzhen Receives Approval from Ministry of Commerce of PRC for Proposed Acquisition Of Complete Genomics
Benzinga
Saturday, February 23, 2013
Benzinga's M&A Chatter for Friday February 22, 2013
Benzinga
BGI-Shenzhen Extends Tender Offer for Complete Genomics to Friday, February 22, 2013
Benzinga
Thursday, February 07, 2013
BGI-Shenzhen Extends Tender Offer For Complete Genomics to Friday, February 22, 2013
Benzinga
Saturday, January 26, 2013
BGI-Shenzhen Extends Tender Offer for Complete Genomics
Benzinga
Saturday, January 12, 2013
BGI-Shenzhen and Complete Genomics Receive Clearance from China Regulatory Agency for Merger
Benzinga
BGI-Shenzhen Announces an Additional Extension of Tender Offer for Complete Genomics
Benzinga
Wednesday, January 09, 2013
Benzinga's M&A Chatter for Tuesday January 8, 2013
Benzinga
Tuesday, January 08, 2013
Illumina Withdraws Offer to Buy Complete Geno...
Benzinga
Monday, January 07, 2013
BGI-Shenzhen Extends All-Cash Tender Offer for Complete Genomics to January 11, 2013
Benzinga
Saturday, December 29, 2012
BGI-Shenzhen Extends All-Cash Tender Offer for Complete Genomics
Benzinga
BGI-Shenzhen Receives CFIUS Clearance for Proposed Acquisition of Complete Genomics
Benzinga
Friday, December 14, 2012
BGI-Shenzhen Announces Extension of Tender Offer For Complete Genomics
Benzinga
Thursday, November 22, 2012
Benzinga's M&A Chatter for Wednesday November 21, 2012
Benzinga
Wednesday, November 21, 2012
Illumina Sends Letter to Complete Genomics Board, Expecting No Antitrust Issues with Bid
Benzinga
BGI-Shenzhen Extends Tender Offer For Complete Genomics to December 14, 2012
Benzinga
Friday, November 16, 2012
Illumina Confirms It is 'Party H' in Complete...
Benzinga
Tuesday, November 13, 2012
Complete Genomics Received $3.30/Share Bid from Party H on Nov. 5th, Says Did Not Constitute Superior Proposal
Benzinga
Wednesday, October 24, 2012
FDA Considering Faster Approval Process for Developers of Drugs for Deadly or Debilitating Diseases
Benzinga
Tuesday, October 23, 2012
BGI-Shenzhen Extends Tender Offer For Complete Genomics Shares
Benzinga
Thursday, October 18, 2012
Complete Genomics Reports Favorable Ruling in Patent Suit Against Illumina
Benzinga
Thursday, September 27, 2012
Knome Taking Orders for knoSYS™100
Benzinga
Monday, September 17, 2012
Benzinga's M&A Chatter for Monday September 17, 2012
Benzinga
Morning Market Movers
Benzinga
Benzinga's Top Pre-Market Gainers
Benzinga
A Peek Into The Market Before The Trading Starts
Benzinga
Complete Genomics Will be Acquired by Shenzhen; Holders Will Get $3.15
Benzinga
Tuesday, September 11, 2012
Baird Downgrades Complete Genomics to Neutral...
Benzinga
Friday, August 31, 2012
Watchlist for Friday, Aug 31
Benzinga
Thursday, August 30, 2012
Hearing Chatter in Complete Genomics
Benzinga
Complete Genomics Spikes to High, $3.09
Benzinga
Friday, August 10, 2012
Benzinga's Microcap Movers for Thursday August 9, 2012
Benzinga
Thursday, August 09, 2012
Benzinga's M&A Chatter for Thursday August 9, 2012
Benzinga
Complete Genomics Cancels Conference Call
Benzinga
Friday, July 27, 2012
Social Media Outlook for Friday July 27 (NYT, XNPT, GDOT, STRA)
Benzinga
Wednesday, July 25, 2012
Benzinga's M&A Chatter for Wednesday July 25, 2012
Benzinga
Complete Genomics Spiking Higher on Takeover ...
Benzinga
Complete Genomics Spiking Higher on Takeover ...
Benzinga
Monday, July 23, 2012
Complete Genomics Spiking Higher
Benzinga
Monday, July 16, 2012
McNicoll Lewis Vlak Suspends Coverage on Comp...
Benzinga
Friday, July 13, 2012
Social Media Outlook, Friday July 13
Benzinga
Thursday, July 12, 2012
Complete Genomics Rises 15% Pre-Market
Benzinga
Benzinga's Top Pre-Market Gainers
Benzinga
Wednesday, July 11, 2012
Complete Genomics Pops 30% on New Technology Development
Benzinga
Complete Genomics Announces New Technology Developed to Set Standard for Clinical-Grade Genomes
Benzinga
Show More